Viking Therapeutics

Yahoo Finance • 15 hours ago

Could Eli Lilly Turn Today's GLP‑1 Obesity Boom Into Multi‑Decade, Millionaire‑Maker Gains?

Key Points Demand for weight loss drugs is high, and analysts predict the market may reach nearly $100 billion in a few years. Eli Lilly dominates the GLP-1 market in the U.S.10 stocks we like better than Eli Lilly › Eli Lilly(NYSE: LLY)... Full story

Yahoo Finance • 3 days ago

Hims & Hers Health Stops Offering Wegovy Pill Knockoff Over FDA Crackdown

Hims & Hers backed down under FDA pressure two days just after launching the copycat version of Novo Nordisk's weight-loss pill. Continue Reading... Full story

Yahoo Finance • 3 days ago

3 Things Investors Need to Know About the Healthcare Sector in 2026

Despite the last few years of remarkable advances in medicine, for investors considering buying healthcare stocks in 2026, this isn't a year to go on autopilot. Valuations of healthcare stocks aren't cheap, winning investments of yesteryea... Full story

Yahoo Finance • 7 days ago

Obesity stocks slump on Novo's underwhelming 2026 sales forecast

Feb 3 (Reuters) - Shares of obesity drugmakers and developers slid on Tuesday after Novo ​Nordisk forecast a sharper-than-expected sales decline ‌for 2026, underscoring intensifying competition in the blockbuster weight-loss market. Eli ‌... Full story

Yahoo Finance • last month

2 Beaten-Down Stocks That Could Bounce Back in 2026

Key Points Viking Therapeutics has important catalysts on the horizon. Zoetis looks well-positioned to overcome recent challenges. 10 stocks we like better than Viking Therapeutics › One great way to earn above-average market returns is... Full story

Yahoo Finance • 2 months ago

Viking Therapeutics (VKTX) Is Up 8.9% After Rival Data Bolsters Its Oral Obesity Program

In recent days, analyst Joseph Pantginis of H.C. Wainwright reaffirmed a positive stance on Viking Therapeutics after competitor Eli Lilly’s successful Phase 3 oral obesity study appeared to support Viking’s own oral obesity drug program.... Full story

Yahoo Finance • 2 months ago

Stocks making the biggest moves midday: Novo Nordisk, ServiceNow, Freeport-McMoRan, Structure Therapeutics & more

Check out the companies making headlines in midday trading. ServiceNow — Shares of the software company fell nearly 3% after it said it would acquire cybersecurity startup Armis for $7.75 billion . The deal, which should close next year, w... Full story

Yahoo Finance • 2 months ago

Novo Nordisk Jumps As FDA OKs Wegovy Pill As First-Ever Oral GLP-1 Weight Loss Drug

The FDA approved Novo Nordisk's Wegovy pill as the first oral GLP-1 treatment for weight loss. The Danish drug giant jumped overnight. Continue Reading... Full story

Yahoo Finance • 2 months ago

Here is Why H.C. Wainwright Sees Immense Upside for Viking Therapeutics (VKTX)

Viking Therapeutics (NASDAQ:VKTX) is one of the most promising mid-cap healthcare stocks under $50. On December 18, H.C. Wainwright analyst Joseph Pantginis reaffirmed his Buy rating on Viking Therapeutics (NASDAQ:VKTX). The analyst has f... Full story

Yahoo Finance • 2 months ago

Viking Therapeutics, Inc. (VKTX): A Bull Case Theory

We came across a bullish thesis on Viking Therapeutics, Inc. on Alpha Talon Investment Research’s Substack by AT Investment Research. In this article, we will summarize the bulls’ thesis on VKTX. Viking Therapeutics, Inc.'s share was tradi... Full story

Yahoo Finance • 2 months ago

2 Growth Stocks to Invest $1,000 in Right Now

Key Points A $1,000 investment can be an ideal amount to invest in an up-and-coming growth stock. The stocks below are still modest in size, with market capitalization of less than $6 billion. Such holdings come with risks, but they also... Full story

Yahoo Finance • 2 months ago

1 Bold Prediction for Viking Therapeutics in 2026

Key Points Takeover activity has been high lately in the intensely competitive anti-obesity drug space. Viking's pipeline may contain plenty of hidden value that a larger company might release. 10 stocks we like better than Viking Therap... Full story

Yahoo Finance • 2 months ago

Telix Pharma (TLX) Makes Progress With New Study

We recently published 7 Best ASX Stocks to Buy Right Now.  Telix Pharmaceuticals Limited (NASDAQ:TLX) is one of the best ASX stocks. Telix Pharmaceuticals Limited (NASDAQ:TLX) is a biotechnology company developing treatments for ailments... Full story

Yahoo Finance • 2 months ago

This is why Viking Therapeutics, Inc. (VKTX) is a Strong Buy on Wall Street

Viking Therapeutics, Inc. (NASDAQ:VKTX) is one of the best biotech stocks to buy according to Wall Street analysts. On November 20, H.C. Wainwright reaffirmed its Buy rating and $102 price target on Viking Therapeutics, Inc. (NASDAQ:VKTX)... Full story

Yahoo Finance • 2 months ago

3 Underrated Growth Stocks That Look Like Great Buys Heading Into 2026

Key Points The best-performing stock on this list is up just 4% this year. Investors may be undervaluing these companies' growth opportunities. Their valuations look attractive and could result in significant gains ahead. 10 stocks we lik... Full story

Yahoo Finance • 2 months ago

Eli Lilly's Experimental Obesity Drug Cut Weight By 23.7%

Eli Lily rose above a key level after saying its experimental obesity treatment delivered 23.7% weight loss in a late-stage trial. Continue Reading... Full story

Yahoo Finance • 2 months ago

Unusual Bullish Options Activity Could Be A Game Changer For Viking Therapeutics (VKTX)

In recent days, options scanners identified unusually large and mostly bullish options trades in Viking Therapeutics, pointing to elevated interest from major investors. This burst of complex options activity suggests that some large marke... Full story

Yahoo Finance • 2 months ago

Viking Therapeutics (VKTX) VANQUISH-1 Trial Completes Early, H.C. Wainwright Retains Buy Rating

Viking Therapeutics, Inc. (NASDAQ:VKTX) ranks among the best short squeeze stocks to buy right now. On November 20, H.C. Wainwright retained its Buy rating and $102 price target for Viking Therapeutics, Inc. (NASDAQ:VKTX) following the end... Full story

Yahoo Finance • 2 months ago

Prediction: This Undervalued Stock Could Compete With Novo Nordisk by 2029

Key Points Viking Therapeutics could enter the weight loss market by 2029. The company's leading candidate looks very promising. The biotech is somewhat risky, but it also offers attractive upside potential. 10 stocks we like better than... Full story

Yahoo Finance • 3 months ago

Novo Nordisk Dives As Ozempic Fails To Slow Alzheimer's; Lilly Falls, Biogen Jumps

Novo Nordisk reported Monday that a Ozempic pill failed to slow the progression of Alzheimer's in two big studies. Novo dived, Eli Lilly fell. Biogen rose. Continue Reading View Comments... Full story